Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063575) titled 'Real-World Incidence and Risk Factors of TARLAtamab-Associated Pneumonitis:... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063568) titled 'Assessment of the Disease Burden of Hymenoptera Venom Allergy in Japan and ... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063513) titled 'Effect of a Hinokitiol-Containing Oral Care Gel on Perioperative Oral Bacte... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063452) titled 'Effects of a Serious Game on Learning Ventilator Weaning Assessment Among N... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062471) titled 'Development and Feasibility of Midwife-led Birth Review Considering for Psy... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060178) titled 'Effects of 6-week intake of krill oil on physical and mental health in heal... Read More
Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060143) titled 'Effects of krill oil intake on physical and mental health in healthy adults... Read More
Singapore, Nov. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single- and Multiple-Ascending Dose Escalation Study to ... Read More
Singapore, Nov. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Part... Read More
Singapore, Nov. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-... Read More